Journal of Integrated Care Pathways > Volume 12, Number 1 > Pp. 10-22

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chew, S. Articles by Sturman, S. Search for Related Content Social Bookmarking                      What's this?

Original articles

Thrombolysis in acute ischaemic stroke pathway

Samuel Chew ^* , Shahid A Kausar ^* and Steve Sturman 

^* Department of Geriatric Medicine; Department of Neurology, City Hospital, Birmingham, UK

Correspondence to: SC Email: samuel.chew{at}swbh.nhs.uk

Thrombolysis of appropriate and selected patients presenting with an acute ischaemic stroke within 3 h of onset with recombinant Tissue Plasminogen Activator (alteplase, r-TPA) can be implemented safely, reduce long-term disability, and is recommended by the National Institute of Health and Clinical Excellence and the Department of Health's National Stroke Strategy. We have developed an integrated and comprehensive pathway in order to achieve the above aims, which also provide guidelines for nursing in the peri-acute period and management of complications arising from the ischaemic stroke itself, from thrombolysis or from concomitant hyperglycaemia.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?